Serina Therapeutics, Inc.
SER
$1.77
-$0.13-6.84%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | 130.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | 130.00K | -- |
| Cost of Revenue | 3.20M | 3.40M | 3.65M | 3.15M | 2.95M |
| Gross Profit | -3.20M | -3.40M | -3.65M | -3.02M | -2.95M |
| SG&A Expenses | 3.08M | 2.81M | 2.74M | 2.54M | 2.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.28M | 6.21M | 6.39M | 5.70M | 5.86M |
| Operating Income | -6.28M | -6.21M | -6.39M | -5.57M | -5.86M |
| Income Before Tax | -6.89M | -3.32M | -4.60M | -6.46M | -4.82M |
| Income Tax Expenses | 7.00K | 18.00K | -- | -- | -- |
| Earnings from Continuing Operations | -6.90M | -3.34M | -4.60M | -6.46M | -4.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | 10.00K | 14.00K | 9.00K |
| Net Income | -6.90M | -3.34M | -4.59M | -6.45M | -4.81M |
| EBIT | -6.28M | -6.21M | -6.39M | -5.57M | -5.86M |
| EBITDA | -6.26M | -6.18M | -6.38M | -5.55M | -5.84M |
| EPS Basic | -0.57 | -0.32 | -0.45 | -0.66 | -0.49 |
| Normalized Basic EPS | -0.27 | -0.19 | -0.28 | -0.40 | -0.31 |
| EPS Diluted | -0.58 | -0.32 | -0.45 | -0.66 | -0.49 |
| Normalized Diluted EPS | -0.27 | -0.19 | -0.28 | -0.40 | -0.31 |
| Average Basic Shares Outstanding | 12.05M | 10.66M | 10.34M | 10.00M | 9.76M |
| Average Diluted Shares Outstanding | 12.05M | 10.66M | 10.34M | 10.00M | 9.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |